Risk Factors and In-Hospital Outcomes of Perioperative Atrial Fibrillation for Patients with Cancer: A Meta-Analysis

被引:2
|
作者
Inoue, Keiko [1 ]
Tajiri, Kazuko [1 ,2 ]
Xu, DongZhu [1 ]
Murakoshi, Nobuyuki [1 ]
Ieda, Masaki [1 ]
机构
[1] Univ Tsukuba, Fac Med, Dept Cardiol, Tsukuba, Ibaraki, Japan
[2] Natl Canc Ctr Hosp East, Dept Cardiol, Kashiwa, Chiba, Japan
关键词
LUNG-CANCER; THORACIC-SURGERY; ESOPHAGEAL; PROPHYLAXIS; AMIODARONE; PREVENTION; MORBIDITY; TRIAL; AGE; ARRHYTHMIAS;
D O I
10.1245/s10434-022-12690-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Perioperative atrial fibrillation is a common postoperative complication. Adverse consequences associated with POAF include hemodynamic instability, increased risk of stroke, extended hospital stays, and increased mortality. Methods To determine the risk factors for POAF and to investigate the outcomes of POAF for patients with cancer, a systematic search of the PubMed and Cochrane Library databases was conducted from inception of the study to 1 September 2021. The inclusion criteria specified studies reporting the prevalence of POAF among patients with cancer. The study excluded articles not written in English, review articles, case reports, letters, commentaries, systematic reviews, meta-analyses, and conference abstracts. Results The search identified 49 studies with 201,081 patients, and the pooled prevalence of POAF was 13.5% (95% confidence interval [CI], 11.6-15.7%). Meta-analyses showed that the incidence of POAF among patients with cancer was associated with age (mean difference [MD], 4.31; 95%CI, 3.16-5.47), male sex (odds ratio [OR], 1.39; 95% CI, 1.19-1.62), chronic obstructive pulmonary disease (OR, 2.47; 95% CI, 1.71-3.56), hypertension (OR, 1.47; 95% CI, 1.23-1.75), intraoperative blood transfusion (OR, 4.58; 95% CI, 2.31-9.10), and open surgery (OR, 1.51; 95% CI, 1.26-1.81). Patients with POAF had significantly higher in-hospital mortality (OR, 4.25; 95% CI, 2.79-6.45), longer hospital stays (MD, 3.07; 95% CI, 1.63-4.51), and higher incidences of pneumonia (OR, 3.32; 95% CI, 2.85-3.86), stroke (OR, 6.57; 95% CI, 1.56-26.00), and myocardial infarction (OR, 3.00; 95% CI, 1.45-6.20) than those without POAF. Conclusions For patients with cancer, POAF is associated with an increased burden of comorbidities and worse outcomes.
引用
收藏
页码:711 / 721
页数:11
相关论文
共 50 条
  • [31] Risk factors for the recurrence of atrial fibrillation after catheter ablation: a meta-analysis
    Gonghao Li
    Yanli Zhao
    Zhongxing Peng
    Yunfeng Zhao
    The Egyptian Heart Journal, 77 (1)
  • [32] LEFT ATRIAL APPENDAGE MORPHOLOGY AND STROKE RISK IN PATIENTS WITH ATRIAL FIBRILLATION: A META-ANALYSIS
    Lupercio, Florentino
    Diaz, Juan Carlos
    Spinetto, Pedro Villablanca
    Briceno, David
    Romero, Jorge
    Gonzalez, Susana
    Maraboto, Carola
    Krumerman, Andrew
    Garcia, Mario
    Natale, Andrea
    Di Biase, Luigi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 713 - 713
  • [33] Perioperative atrial fibrillation and risk of stroke after cardiac surgery: a systematic review and meta-analysis
    Wang, M. K.
    Chen, P.
    Meyre, P.
    Ali, M. Z.
    Heo, R.
    McIntyre, W.
    Healey, J.
    Whitlock, R.
    Lamy, A.
    Devereaux, P. J.
    Conen, D.
    EUROPEAN HEART JOURNAL, 2020, 41 : 518 - 518
  • [34] Prevalence of atrial fibrillation in patients with atrial septal defect and its impact on in-hospital outcomes
    Htwe, K.
    Baral, N.
    Aung, T.
    Moza, A.
    Munir, A.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [35] Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis
    Kostopoulos, Georgios
    Doundoulakis, Ioannis
    Antza, Christina
    Bouras, Emmanouil
    Nirantharakumar, Krishnarajah
    Tsiachris, Dimitrios
    Thomas, G. Neil
    Lip, Gregory Y. H.
    Toulis, Konstantinos A.
    ENDOCRINE-RELATED CANCER, 2021, 28 (05) : 325 - 335
  • [36] Perioperative Atrial Fibrillation Increased Risks of Stroke and Mortality: A Meta-Analysis
    Lin, Meng-Hsin
    Kamel, Hooman
    Singer, Daniel E.
    Wu, Yi-Ling
    Lee, Meng
    STROKE, 2018, 49
  • [37] Outcomes in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a survival meta-analysis
    Masri, Ahmad
    Kanj, Mohamed
    Thamilarasan, Maran
    Wazni, Oussama
    Smedira, Nicholas G.
    Lever, Harry M.
    Desai, Milind Y.
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2017, 7 (01) : 36 - 44
  • [38] Association of natriuretic peptide and adverse outcomes in patients with atrial fibrillation: A meta-analysis
    Du, Hong
    Yang, Lei
    Zhang, Hui
    Zhang, Xiaolin
    Shao, Huiyu
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2021, 48 (02) : 161 - 169
  • [39] Meta-Analysis of Cardiovascular Outcomes With Dronedarone in Patients With Atrial Fibrillation or Heart Failure
    Chatterjee, Saurav
    Ghosh, Joydeep
    Lichstein, Edgar
    Aikat, Shamik
    Mukherjee, Debabrata
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (04): : 607 - 613
  • [40] Warfarin anticoagulation and outcomes in atrial fibrillation patients: A systematic review and meta-analysis
    Reynolds, MW
    Nalysnyk, L
    Fahrbach, K
    Hauch, O
    Wygant, G
    Estok, R
    Frame, D
    Cella, C
    Scheye, R
    Ross, S
    VALUE IN HEALTH, 2004, 7 (03) : 320 - 320